BioLine Rx Cash from Investing (TTM) Analysis

BioLine Rx Ltd (BLRX)

0.613 -0.02 (-3.74%) USD | NASDAQ | Apr 24, 16:00

0.6101 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2010. Upgrade now.

Date	Value
December 31, 2023	1.444M
September 30, 2023	25.70M
June 30, 2023	6.669M
March 31, 2023	5.60M
December 31, 2022	4.006M
September 30, 2022	4.142M
June 30, 2022	19.12M
March 31, 2022	3.085M
December 31, 2021	-38.22M
September 30, 2021	-33.68M
June 30, 2021	-26.18M
March 31, 2021	-25.78M
December 31, 2020	16.67M
September 30, 2020	11.32M
June 30, 2020	8.962M
March 31, 2020	20.76M
December 31, 2019	5.257M
September 30, 2019	-4.376M
June 30, 2019	-4.339M
March 31, 2019	-7.842M
December 31, 2018	9.555M
September 30, 2018	19.60M
June 30, 2018	10.84M
March 31, 2018	-9.21M
December 31, 2017	-15.93M

Date	Value
September 30, 2017	-17.55M
June 30, 2017	-10.89M
March 31, 2017	9.01M
December 31, 2016	9.297M
September 30, 2016	10.42M
June 30, 2016	6.463M
March 31, 2016	6.724M
December 31, 2015	-15.60M
September 30, 2015	-22.82M
June 30, 2015	-22.13M
March 31, 2015	-21.34M
December 31, 2014	-19.73M
September 30, 2014	-16.04M
June 30, 2014	-14.92M
March 31, 2014	-12.38M
December 31, 2013	-5.318M
September 30, 2013	4.970M
June 30, 2013	5.346M
March 31, 2013	-4.187M
December 31, 2012	13.74M
September 30, 2012	7.550M
June 30, 2012	7.836M
March 31, 2012	9.791M
December 31, 2011	-9.868M
September 30, 2011	-21.80M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-38.22M

Minimum

Dec 2021

25.70M

Maximum

Sep 2023

0.0078M

Average

4.142M

Median

Sep 2022

Cash from Investing (TTM) Benchmarks